Trials / Unknown
UnknownNCT01239719
Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 96 (estimated)
- Sponsor
- Azidus Brasil · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to prove the efficacy of the dexamethasone 0.5 mg + 1 mg clemastine fumarate tablet compared to 0.5 mg of dexamethasone in reducing the signs and symptoms of allergic dermatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone + clemastine | Dexamethasone 0.5 mg clemastine fumarate: 01 tablet every 12 hours. |
| DRUG | Dexamethasone | Dexamethasone 0.5 mg: 01 tablet every 12 hours. |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2011-07-01
- Completion
- 2011-12-01
- First posted
- 2010-11-11
- Last updated
- 2011-01-28
Source: ClinicalTrials.gov record NCT01239719. Inclusion in this directory is not an endorsement.